Tech Company Financing Transactions

Tessera Therapeutics Funding Round

Tessera Therapeutics, based in Cambridge, received $300 million in investment from Abu Dhabi Investment Authority, Alaska Permanent Fund and Altitude Life Science Ventures.

Transaction Overview

Announced On
4/19/2022
Transaction Type
Venture Equity
Amount
$300,000,000
Round
Series C
Proceeds Purpose
This latest funding round is a testament to the immense potential of this bioplatform to provide new treatments and cures to previously untreatable genetic diseases.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
55 Cambridge Pkwy. 800E
Cambridge, MA 02142
USA
Phone
Undisclosed
Email Address
Overview
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source.
Profile
Tessera Therapeutics LinkedIn Company Profile
Social Media
Tessera Therapeutics Company Twitter Account
Company News
Tessera Therapeutics News
Facebook
Tessera Therapeutics on Facebook
YouTube
Tessera Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Geoffrey von Maltzahn
  Geoffrey von Maltzahn LinkedIn Profile  Geoffrey von Maltzahn Twitter Account  Geoffrey von Maltzahn News  Geoffrey von Maltzahn on Facebook
Chief Scientific Officer
Jacob Rubens
  Jacob Rubens LinkedIn Profile  Jacob Rubens Twitter Account  Jacob Rubens News  Jacob Rubens on Facebook
Vice President
Stephen Cleaver
  Stephen Cleaver LinkedIn Profile  Stephen Cleaver Twitter Account  Stephen Cleaver News  Stephen Cleaver on Facebook
Vice President
Cecilia Cotta-Ramusino
  Cecilia Cotta-Ramusino LinkedIn Profile  Cecilia Cotta-Ramusino Twitter Account  Cecilia Cotta-Ramusino News  Cecilia Cotta-Ramusino on Facebook
VP - Bus. Development
Vikram Ranade
  Vikram Ranade LinkedIn Profile  Vikram Ranade Twitter Account  Vikram Ranade News  Vikram Ranade on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/19/2022: The Food Lab venture capital transaction
Next: 4/19/2022: Experify venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document every notable VC transaction. All VC database entries on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary